Evidence map›Paper›PMID 30065032›Full record

Trial reportDiabetes2018

Interaction of GLP-1 and Ghrelin on Glucose Tolerance in Healthy Humans.

Laura C Page, Amalia Gastaldelli, Sarah M Gray, David A D'Alessio, Jenny Tong

Open access · bronzeAbstract readClinical Trial
In one paragraph

Trial report in Diabetes, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 31 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. An Emerging Role for Gut-Brain Signaling Involving Ghrelin in Chronic Stress.Advances in experimental medicine and biology · 2025
    Review
  5. Article
  6. Article
  7. Ghrelin receptor signaling in health and disease: a biased view.Trends in endocrinology and metabolism: TEM · 2023
    Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Ghrelin regulation of glucose metabolism.Journal of neuroendocrinology · 2019
    Review
  16. Incretin dysfunction and hyperglycemia in cystic fibrosis: Role of acyl-ghrelin.Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society · 2019
    Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Laura C PageDivision of Endocrinology, Department of Pediatrics, Duke University, Durham, NC.ORCID 0000-0002-6477-9258
Amalia GastaldelliInstitute of Clinical Physiology, National Research Council, Pisa, Italy.ORCID 0000-0003-2594-1651
Sarah M GrayDuke Molecular Physiology Institute, Duke University, Durham, NC.
David A D'AlessioDuke Molecular Physiology Institute, Duke University, Durham, NC.
Jenny TongDuke Molecular Physiology Institute, Duke University, Durham, NC jenny.tong@duke.edu.ORCID 0000-0002-5614-3671
Duke University · USIstituto di Fisiologia Clinica · IT

Funding

LCenter for Clinical and Translational Science and TrainingUL1TR001425 · NCATS · UNIVERSITY OF CINCINNATI · PI MEINZEN-DERR, JAREEN, STRAWN, JEFFREY ROBERT · 2015 to 2024
$37.5M
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR026314 · NCRR · UNIVERSITY OF CINCINNATI · PI HEUBI, JAMES E. · 2009 to 2011
$14.3M
Endocrinology and Metabolism Training ProgramT32DK007012 · NIDDK · DUKE UNIVERSITY · PI DAVID A. D'ALESSIO · 1986 to 2026
$6.8M
Duke Research Training Program for PediatriciansT32HD043029 · NICHD · DUKE UNIVERSITY · PI BENJAMIN, DANIEL K. · 2002 to 2017
$3.7M
Incretin Action in Physiology and DiabetesR01DK101991 · NIDDK · DUKE UNIVERSITY · PI D'ALESSIO, DAVID A. · 2014 to 2018
$1.8M
The Role of Ghrelin to Regulate Insulin Secretion in Health and Diabetes.R01DK097550 · NIDDK · UNIVERSITY OF CINCINNATI · PI TONG, JENNY · 2013 to 2017
$1.7M
NCATS NIH HHS UL1 TR001425NCRR NIH HHS UL1 RR026314NICHD NIH HHS T32 HD043029NIDDK NIH HHS R01 DK097550NIDDK NIH HHS R01 DK101991NIDDK NIH HHS T32 DK007012
6 · The paper itself

Abstract

Emerging evidence supports the importance of ghrelin to defend against starvation-induced hypoglycemia. This effect may be mediated by inhibition of glucose-stimulated insulin secretion as well as reduced insulin sensitivity. However, administration of ghrelin during meal consumption also stimulates the release of glucagon-like peptide 1 (GLP-1), an incretin important in nutrient disposition. The objective of this study was to evaluate the interaction between ghrelin and GLP-1 on parameters of glucose tolerance following a mixed-nutrient meal. Fifteen healthy men and women completed the study. Each consumed a standard meal on four separate occasions with a superimposed infusion of

Indexed as

AdolescentAdultBlood GlucoseFemaleGhrelinGlucagon-Like Peptide 1Glucagon-Like Peptide-1 ReceptorGlucoseGlucose IntoleranceHumansInsulinMalePostprandial PeriodYoung AdultBlood GlucoseGhrelinGlucagon-Like Peptide 1Glucagon-Like Peptide-1 ReceptorGlucoseInsulin

Identifiers

PMID30065032
PMCPMC6152343
OpenAlexW2887886260

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.